MBIO Mustang Bio Corp: Future Profit

Symbol and logo of brand Mustang Bio (MBIO)

Mustang Bio, Inc. (MBIO) combines a scientific approach with clinical expertise in CAR-T therapy. This reputation is bolstered by the implementation of ESG standards and the greening of its manufacturing plants. Promising net income illustrates the link between ethics and physician trust, where the metric serves as the target level. In the future, the development of innovative cancer treatment products will ensure rapid growth for the company.

MBIO: Mustang Bio Corp Projected Future Earnings 07/04/2022 - 11/18/2026

Summary analytical data breakdowns for Mustang Bio, Inc. (MBIO)

- price and consensus price forecast:
Fundamental company valuation:Mustang Bio, MBIO
Finished products of Mustang Bio Corp

To select high-quality assets, an investor must evaluate a business's resilience to macroeconomic shocks. This indicator measures the impact of tight Fed policy on net income through operating margin compression. For Mustang Bio, Inc. (MBIO), which invests in costly R&D and CAR-T therapy, borrowing costs critically affect development rates. Analyzing the forward yield allows for an assessment of the biotech's ability to preserve capital. Rising values confirm the issuer's strength, although peaks on the chart signal a risk of overpayment.

Key competitors

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Expected Profit RGEN (Repligen Corp.)|Avidity - Future Profit|CRSP (crisprtx.com) - Forward Earnings|WGS: Future Profit|Projected Net Profit Ultragenyx (RARE)|BEAM: Projected Future Earnings|Sarepta Therapeutics, Inc. (SRPT) - Projected Future Earnings|TWST (twistbioscience.com) - Projected Future Earnings|10x Genomics, Inc. (TXG) - Company Profit Forecast|Future Profit NTLA (Intellia Therapeutics, Inc.)|STOK - Expected Net Profit|Expected Profit biolifesolutions.com BLFS|Company Profit Forecast Wave Life Sciences Corp (WVE)|MAZE - Expected Profit|Expected Net Income SION (Sionna Therapeutics Inc)|PRME: Projected Future Earnings|Taysha - Expected Net Income|Expected Profit uniQure NV|Net Profit Forecast MGTX (MeiraGTx PLC)|Future Profit RGNX (regenxbio.com)|Solid Biosciences Inc. - Net Profit Forecast|Expected Profit Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Expected Net Profit|BNTC - Expected Profit|Design Pharma - Future Net Profit|RCKT (Rocket Pharmaceuticals Inc) - Future Profit|4D Molecular Therapeutics (FDMT) - Projected Future Earnings|Expected Profit Lexeo Therapeutics, Inc.|Expected Net Profit Korro Bio, Inc. KRRO|Projected Future Earnings EDIT|Company Profit Forecast Silence Therapeutics Corp|Expected Profit proqr.com PRQR|CDXS - Future Profit|SGMO - Expected Profit|Projected Net Profit Nautilus Biotechnology, Inc. (NAUT)|MGX: Projected Future Earnings|Net Profit Forecast DTIL|GBIO (Generation Bio) - Projected Future Earnings|Net Profit Forecast BOLD (boundlessbio.com)|Future Profit XCUR (exicuretx.com)|Celsion Corporation - Net Profit Forecast|Projected Future Earnings PHIO (phiopharma.com)|Projected Future Earnings transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Projected Future Earnings|APDN (Applied DNA Sciences) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings